- CVRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
3 Filing
CVRx (CVRX) Form 3CVRx / DEAN BRUHN-DING ownership change
Filed: 29 Jun 21, 9:04pm
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 06/29/2021 | 3. Issuer Name and Ticker or Trading Symbol CVRx, Inc. [ CVRX ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 5,648 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option | (1) | 08/06/2025 | Common Stock | 1,169 | 0.237 | D | |
Stock Option | (1) | 08/06/2025 | Common Stock | 821 | 0.237 | D | |
Stock Option | (1) | 08/06/2025 | Common Stock | 378 | 0.237 | D | |
Stock Option | (1) | 08/06/2025 | Common Stock | 1,590 | 0.237 | D | |
Stock Option | (1) | 08/06/2025 | Common Stock | 2,528 | 0.237 | D | |
Stock Option | (1) | 08/06/2025 | Common Stock | 2,275 | 0.237 | D | |
Stock Option | (1) | 11/11/2023 | Common Stock | 2,862 | 0.237 | D | |
Stock Option | (1) | 09/10/2024 | Common Stock | 1,264 | 0.237 | D | |
Stock Option | (1) | 02/16/2025 | Common Stock | 1,264 | 0.237 | D | |
Stock Option | (1) | 06/30/2025 | Common Stock | 2,528 | 0.237 | D | |
Stock Option | (1) | 09/27/2026 | Common Stock | 7,206 | 0.237 | D | |
Stock Option | (2) | 02/15/2028 | Common Stock | 15,095 | 0.237 | D | |
Stock Option | (3) | 02/15/2028 | Common Stock | 16,511 | 0.237 | D | |
Stock Option | (4) | 07/23/2029 | Common Stock | 19,318 | 3.955 | D | |
Stock Option | (1) | 09/30/2030 | Common Stock | 9,671 | 4.35 | D | |
Stock Option | (5) | 09/30/2030 | Common Stock | 9,535 | 4.35 | D | |
Stock Option | (6) | 09/30/2030 | Common Stock | 8,670 | 4.35 | D | |
Stock Option | (7) | 09/30/2030 | Common Stock | 8,589 | 4.35 | D | |
Stock Option | (8) | 02/03/2031 | Common Stock | 18,963 | 7.119 | D |
Explanation of Responses: |
1. Fully vested. |
2. Fully exercisable, subject to Issuer's right to repurchase shares at the exercise price, which repurchase right lapsed with respect to 25% of the shares on February 26, 2019 and lapses with respect to the 1/48th of the shares each month thereafter. |
3. Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares on the 15th of each month thereafter. |
4. Vested as to 25% of the shares on July 24, 2020 and vests as to 1/48th of the shares each month thereafter. |
5. Vests as to 75% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter. |
6. Vests as to 25% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter. |
7. Vests as to 25% of the shares on October 1, 2021 and as to 1/48th of the shares each month thereafter. |
8. Vests as to 25% of the shares on February 4, 2022 and as to 1/48th of the shares each month thereafter. |
/s/ Amy C. Seidel, Attorney-in-Fact | 06/29/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |